Abdominal multidetector CT in patients with varying body fat percentages: Estimation of optimal contrast material dose

Radiology

Volumn 249, Issue 3, 2008, Pages 872-877

  Kondo, Hiroshi ^a,b   Kanematsu, Masayuki ^b,c   Goshima, Satoshi ^b   Tomita, Yuhei ^a   Miyoshi, Toshiharu ^b   Hatcho, Atsushi ^d   Moriyama, Noriyuki ^e   Onozuka, Minoru ^c   Shiratori, Yoshimune ^b   Bae, Kyongtae T ^f  

^a Kizawa Memorial Hospital   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

^d NAGANO RED CROSS HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IOHEXOL; CONTRAST MEDIUM;

ADULT; AGED; AORTA; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTAL VEIN; PRIORITY JOURNAL; ABDOMINAL RADIOGRAPHY; ADIPOSE TISSUE; AORTOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HISTOLOGY; LIVER; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; AORTOGRAPHY; BODY MASS INDEX; BODY WEIGHT; CONTRAST MEDIA; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; RADIOGRAPHY, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149201476     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2492080033     Document Type: Article

References (20)

1. Haider MA, Amitai MM, Rappaport DC, et al. Multi-detector row helical CT in preoperative assessment of small (≤1.5 cm) liver metastases: is thinner collimation better? Radiology 2002;225:137-142.
2. Goshima S, Kanematsu M, Kondo H, et al. MDCT of the liver and hypervascular hepa- tocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol 2006;187:W25-W32.
3. Small WC, Nelson RC, Bernardino ME, Brummer LT. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement. AJR Am J Roentge- nol 1994;163:87-92.
4. Freeny PC, Gardner JC, von Ingersleben G, Heyano S, Nghiem HV, Winter TC. Hepatic helical CT: effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Radiology 1995;197:89-93.
5. Valls C, Andia E, Sanchez A, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectabil-ity with helical CT. Radiology 2001;218: 55- 60.
6. Abdelmoumene A, Chevallier P, Chalaron M, et al. Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT). Eur Radiol 2005;15:1881-1887.
7. Valette PJ, Pilleul F, Crombe-Ternamian A. MDCT of benign liver tumors and metastases. Eur Radiol 2003;13(suppl 5):M31-M41.
8. Marchiano A. MDCT of primary liver malignancies. Eur Radiol 2003;13(suppl 5):M26-M30.
9. Yamashita Y, Komohara Y, Takahashi M, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material-a prospective randomized study. Radiology 2000;216:718-723.
10. Awai K, Takada K, Onishi H, et al. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi- detector row helical CT. Radiology 2002;224:757-763.
11. Foley WD, Hoffmann RG, Quiroz FA, Kahn CE Jr, Perret RS. Hepatic helical CT: contrast material injection protocol. Radiology 1994;192:367-371.
12. Tublin ME, Tessler FN, Cheng SL, Peters TL, McGovern PC. Effect of injection rate of con- trast medium on pancreatic and hepatic helical CT. Radiology 1999;210:97-101.
13. Kondo H, Kanematsu M, Satoshi G, et al. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement. AJR Am J Roentgenol 2007;188:751-756.
14. Heiken JP, Brink JA, McClenan BL, et al. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight. Radiology 1995;195:353-357.
15. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-662.
16. Ho LM, Nelson RC, Delong DM. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi- detector row CT? Radiology 2007;243:431- 437.
17. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. I. Prediction with a computer model. Radiology 1998;207:647- 655.
18. Kormano M, Partanen K, Soimakallio S, Kivimaeki T. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 1983;18:364-367.
19. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997;203:605- 610.
20. Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol1998;171:933-939.